UPDATE: Morgan Stanley Upgrades athenahealth on Inflection Point

In a report published Wednesday, Morgan Stanley analyst Ricky R. Goldwasser upgraded the rating on

from Equal-Weight to Overweight, and raised the price target from $133.00 to $192.00. In the report, Morgan Stanley noted, “Coordinator Enterprise deals mark an inflection point for ATHN. Our analysis of the hospital market shows a current inpatient TAM of ~$34B, growing to ~$83B by 2030. Feedback from CIOs we met with at HIMSS point to the resonance of the healthcare cloud and growing awareness of ATHN's platform. "We model ATHN gaining 5% inpatient share by 2030. In the NT we model Coordinator Enterprise revs of $30M/$80M in 2015/16. Our 2014/15 rev estimates of $964M/$1,239M and EPS of $1.42/$1.95 are ahead of cons' $918M/$1,130M and EPS of $1.31/$1.82 respectively.” athenahealth closed on Tuesday at $134.12.